Skip to main content
Premium Trial:

Request an Annual Quote

NIH Commits $1M for Genomic Innovator Awards

NEW YORK (GenomeWeb) — The National Institutes of Health has set aside $1 million in fiscal 2019 to fund its Genomic Innovator Awards, which aim to enable investigators working within groups to pursue independent research.

"Many investigators in genomics start their careers in such groups, which do not always provide traditional opportunities for career development such as leading independent research projects and writing first-author publications," the NIH said. "Such individuals can face hurdles when applying for standard NIH awards, since their contributions and creativity can be difficult to recognize."

To help address this issue, the NIH has earmarked $1 million in the coming year to fund two awards for genomics investigators who are making important contributions to team science efforts and show considerable promise for launching their own independent research careers.

While the NIH does not have specific aims for research funded under this program, it is focused on the development of approaches that can be applied generally to the genomics field. "Studies that focus on one or a few specific genes should be paradigm-setting and yield findings relevant at the genomic level," the agency noted.

Additional details about the funding opportunity can be found here.

The Scan

Panel Votes for COVID-19 Pill

A US Food and Drug Administration panel has voted to support the emergency use authorization of an antiviral pill for COVID-19 from Merck and Ridgeback Biotherapeutics, CNN says.

But Not Harm

New Scientist reports that UK bioethicists say that though gene editing may improve food production, it should not harm livestock welfare.

Effectiveness Drop Anticipated

Moderna's Stéphane Bancel predicts that that current SARS-CoV-2 vaccines may be less effective against the Omicron variant, the Financial Times reports.

Cell Studies of Human Chromatin Accessibility, SARS-CoV-2 Variants, Cell Signaling Networks

In Cell this week: chromatin accessibility maps of adult human tissues, modeling to track SARS-CoV-2 variants of concern, and more.